Differential Immunogenicity of mRNA-based and Inactivated Virus COVID-19 Vaccines in Patients with Inflammatory Rheumatic Disease - A Prospective Study up to 12 Months Post-3rd Dose
Background During the COVID-19 pandemic, 2 types of COVID-19 vaccines were made available in Hong Kong - the mRNA-based vaccine and the inactivated virus vaccine. All residents were required to complete 3 vaccinations. There is concern that immunogenicity acquired from COVID-19 vaccinations could be...
Saved in:
| Main Authors: | Nga Sze Wong, Isaac T Cheng, Tracey Yu, Vivien Chan, Tena Li, Lai-Shan Tam, Paul KS Chan, Ho So |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Scientific Publishing
2024-01-01
|
| Series: | Journal of Clinical Rheumatology and Immunology |
| Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341724740432 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity, Efficacy and Twelve-Month Storage Stability Studies of a Lyophilized Rabies mRNA Vaccine
by: Chen Chen, et al.
Published: (2025-07-01) -
Methotrexate and immunogenicity of vaccines in patients with rheumatic diseases
by: В. S. Belov, et al.
Published: (2024-04-01) -
Safety and immunogenicity of inactivated Zika virus vaccine by gamma irradiation
by: Pumin Sintara, et al.
Published: (2025-10-01) -
EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010-07-01) -
Value of immunogenicity in the TNF-α inhibitor treatment of rheumatic diseases
by: N. V. Chichasova
Published: (2016-01-01)